Navigation Links
Does Treatment of Fibroids Guarantee Fertility ?

Women choose to bear the inconvenience of abnormal vaginal bleeding and pelvic pain caused by growth of fibroids in the uterus and fore-go treatment due to fear of losing// fertility as the available treatments do not guarantee fertility.

A study conducted by physicians at Thomas Jefferson University Hospital in Philadelphia published in the December issue of The Female Patient, presents a case history of a 35-year-old women whose numerous fibroids formed a large mass in her pelvic area that, when initially diagnosed, was of a size comparable to a full-term pregnancy.

'Traditionally, treatment for such a large fibroid mass in the uterus has been limited to hysterectomy, because the patient would bleed extensively if an attempt was made to merely remove the fibroids.' says Jay Goldberg, M.D., MSCP, lead author and director of the Jefferson Fibroid Center at Thomas Jefferson University. 'In this particular case though, hysterectomy was not an option because the patient strongly desired future fertility and uterine preservation.'

To meet the patient’s wishes and remove the fibroids, the physicians developed a plan to perform two procedures a month apart.

The Jefferson physicians first performed a uterine fibroid embolization (UFE), a minimally invasive radiologic procedure that blocks the arteries that supply blood to the fibroid tumors. The procedure was done to reduce the blood flow within the patient’s uterus and the risk of hemorrhaging at the time of surgery.

One month later, the patient underwent an abdominal myomectomy. In this procedure, the fibroids are removed through an abdominal skin incision. After the UFE, her initially 38-week sized uterus had decreased to a 34-week size, with decreased blood flow. Eleven large fibroids were removed during the myomectomy, with minimal blood loss. The patient was discharged from the hospital on the second day post-surgery and experienced no complications.

Dr. G
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Dr. Redlener Applauds Historic Effort but Points out Potential Risk if America,s Safety Net Programs Are Lost in Final Health Care Reform ,, NEW YORK, Dec. 4 The New England Journal of Medicine
(Date:12/4/2009)Whether the H1N1 virus will come back during winter isn,t known, CDC says, , , FRIDAY, Dec. 4 (HealthDay News) -- The number of states reporting widespread swine flu activity continued to decl
Breaking Medicine News(10 mins):Health News:Are angry women more like men? 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Swine Flu Continues to Wane 2
...sparked new fears over the safety of Scottish farm...o more than two portions a year.// Researche...tate University, concluded that the health benefit...e health risks will outweigh the benefits, accordi...
...accident has been described as an environmental tr...he blaze. The flames are reportedly spewing out a ...her explosion from a highly volatile fuel tank led...50 fire service personnel drawn from 16 fire servi...
...y the common cold, according to a Newcastle Univer...caused by relatively minor ailments like a respira...ore in the case of those who are genetically susce...nt of a vaccine which will serve to protect childr...
...Palliative care for treatment of chronic diseases ...itals, which has been reported in the Journal of P...patients where chemotherapy or other treatments no...r palliative care. Palliative care programs prov...
...d a non-invasive sensor that will help treat patie... When a patient faces respiratory distress in ... concentrations of oxygen via a mask. But for some...es precious minutes, but the non-invasive sensor c...
...the death of Rene Anderson who took part in a tria...x drug is derived from the plant, and it has been ...ministered to Rene Anderson for relieving her of p...pneumonia and kidney failure. The manufacturers of...
Other Medicine News:Health News:Salmon's own diet sure to affect yours 2Health News:Firefighters Continue To Battle Blaze 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Regence Launches Effort to Further Health Care Debate 51852 1Regence Launches Effort to Further Health Care Debate 51852 2Regence Launches Effort to Further Health Care Debate 51852 3Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 1Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 2Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 3Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 4Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 1Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 2Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 3Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 4Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 5
...SEARCH TRIANGLE PARK, N.C., July 27 Timothy Mastr...tional (FHI) on August 1st,as Senior Director of R...rch into pre-exposure prophylaxis (PrEP) for HIV p...Mexico City., Dr. Mastro,s presentation, titled "...ls," will examine ongoing and upcoming clinical tr...
...nancing will advance the company,s clinical develo... technology platform, PRINCETON, N.J., July 28 C...tical company developing novel,products based on p...y,announced that it raised in excess of $22.5 mill...Series B investors participated in the financing a...
Other Medicine Technology:HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million 2Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million 3
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: